Work

Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation

Year: 2019

Type: article

Source: Bone Marrow Transplantation

DOI: 10.1038/s41409-019-0450-3

Authors: Michelle Schoettler, Christine Duncan, Leslie Lehmann, Elissa Furutani, Meera Subramaniam, Steven Margossian

Institutions: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences

Awards: G359072365, Harvard Clinical and Translational Science Center, Pathophysiology of Human Blood Cells

OpenAlex ID: W2913640804

FWCI: 3.88

Cites: 10

Cited by: 34

Related to: 10